A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells

References

• Bidwell GL, 3rd, Raucher D. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Mol Cancer Ther 2005; 4(7)1076–1085
   PubMed Web of Science ®Google Scholar
• Bidwell GL, 3rd, Fokt I, et al. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochem Pharmacol 2006
   Web of Science ®Google Scholar
• Chilkoti A, Dreher MR, et al. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 2002; 54(5)613–630
   PubMed Web of Science ®Google Scholar
• Del Gaizo Moore V, Payne RM. Transactivator of transcription fusion protein transduction causes membrane inversion. J Biol Chem 2004; 279(31)32541–32544
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Prosnitz L, et al. Hyperthermic treatment of malignant diseases: Current status and a view toward the future. Semin Oncol 1997; 24(6)616–625
   PubMed Web of Science ®Google Scholar
• Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003; 2(5)347–360
   PubMed Web of Science ®Google Scholar
• El-Sayed ME, Hoffman AS, et al. Smart polymeric carriers for enhanced intracellular delivery of therapeutic macromolecules. Expert Opin Biol Ther 2005; 5(1)23–32
   PubMed Web of Science ®Google Scholar
• Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17(1)1–18
   PubMed Web of Science ®Google Scholar
• Feyerabend T, Steeves R, et al. Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies. Anticancer Res 1997; 17(4B)2895–2897
   PubMed Web of Science ®Google Scholar
• Hallbrink M, Floren A, et al. Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta 2001; 1515(2)101–109
   PubMed Web of Science ®Google Scholar
• Hed J, Hallden G, et al. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods 1987; 101(1)119–125
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43(1)33–56
   PubMed Web of Science ®Google Scholar
• Issels RD. Regional hyperthermia combined with systemic chemotherapy of locally advanced sarcomas: Preclinical aspects and clinical results. Recent Results Cancer Res 1995; 138: 81–90
   PubMedGoogle Scholar
• Jung HJ, Park Y, et al. Biological activity of Tat (47–58) peptide on human pathogenic fungi. Biochem Biophys Res Commun 2006; 345(1)222–228
   PubMed Web of Science ®Google Scholar
• Jurisic V, Spuzic I, et al. A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cells, determined by LDH release assay. Cancer Lett 1999; 138(1–2)67–72
   PubMed Web of Science ®Google Scholar
• Kopecek J, Kopeckova P, et al. HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action. Eur J Pharm Biopharm 2000; 50(1)61–81
   PubMed Web of Science ®Google Scholar
• Kurokawa H, Nishio K, et al. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 1999; 6(1)33–37
   PubMed Web of Science ®Google Scholar
• Leuschner C, Hansel W. Membrane disrupting lytic peptides for cancer treatments. Curr Pharm Des 2004; 10(19)2299–2310
   PubMed Web of Science ®Google Scholar
• Liang Y, Yan C, et al. Apoptosis in the absence of caspase 3. Oncogene 2001; 20(45)6570–6578
   PubMed Web of Science ®Google Scholar
• Lindgren M, Hallbrink M, et al. Cell-penetrating peptides. Trends Pharmacol Sci 2000; 21(3)99–103
   PubMed Web of Science ®Google Scholar
• Liu W, Dreher MR, et al. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J Control Release 2006; 116(2)170–178
   PubMed Web of Science ®Google Scholar
• Massodi I, Bidwell GL, 3rd, et al. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Release 2005; 108(2–3)396–408
   PubMed Web of Science ®Google Scholar
• Meyer DE, Chilkoti A. Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat Biotechnol 1999; 17(11)1112–1115
   PubMed Web of Science ®Google Scholar
• Meyer DE, Kong GA, et al. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res 2001; 61(4)1548–1554
   PubMed Web of Science ®Google Scholar
• Meyer DE, Shin BC, et al. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 2001; 74(1–3)213–224
   PubMed Web of Science ®Google Scholar
• Mori S, Watanabe W, et al. A colorimetric LDH assay for the titration of infectivity and the evaluation of anti-viral activity against ortho and paramyxoviruses. Tohoku J Exp Med 1995; 177(4)315–325
   PubMed Web of Science ®Google Scholar
• Nuutila J, Lilius EM. Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytometry A 2005; 65(2)93–102
   PubMed Web of Science ®Google Scholar
• Raucher D, Chilkoti A. Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition. Cancer Res 2001; 61(19)7163–7170
   PubMed Web of Science ®Google Scholar
• Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5(11)897–907
   PubMed Web of Science ®Google Scholar
• Rinne J, Albarran B, et al. Lization of novel non-viral vector TAT-streptavidin into human cells. BMC Biotechnol 2007; 7(1)1
   PubMedGoogle Scholar
• Saar K, Lindgren M, et al. Cell-penetrating peptides: A comparative membrane toxicity study. Anal Biochem 2005; 345(1)55–65
   PubMed Web of Science ®Google Scholar
• Sabatier JM, Vives E, et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 1991; 65(2)961–967
   PubMed Web of Science ®Google Scholar
• Scheller A, Oehlke J, et al. Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J Pept Sci 1999; 5(4)185–194
   PubMed Web of Science ®Google Scholar
• Takahashi I, Emi Y, et al. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery 2002; 131(1Suppl)S78–S84
   PubMedGoogle Scholar
• Tatham AS, Shewry PR. Elastomeric proteins: Biological roles, structures and mechanisms. Trends Biochem Sci 2000; 25(11)567–571
   PubMed Web of Science ®Google Scholar
• Temsamani J, Vidal P. The use of cell-penetrating peptides for drug delivery. Drug Discov Today 2004; 9(23)1012–1019
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 1998; 15(1)1–19
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4(2)145–160
   PubMed Web of Science ®Google Scholar
• Toro A, Grunebaum E. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J Clin Invest 2006; 116(10)2717–2726
   PubMed Web of Science ®Google Scholar
• Trehin R, Merkle HP. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm 2004; 58(2)209–223
   PubMed Web of Science ®Google Scholar
• Vives E. Present and future of cell-penetrating peptide mediated delivery systems: Is the Trojan horse too wild to go only to Troy?. J Control Release 2005; 109(1–3)77–85
   PubMed Web of Science ®Google Scholar
• Wadia JS, Dowdy SF. Modulation of cellular function by TAT mediated transduction of full length proteins. Curr Protein Pept Sci 2003; 4(2)97–104
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3(8)487–497
   PubMed Web of Science ®Google Scholar
• Wu SP, Fu AL, et al. A novel therapeutic approach to 6-OHDA-induced Parkinson's disease in rats via supplementation of PTD-conjugated tyrosine hydroxylase. Biochem Biophys Res Commun 2006; 346(1)1–6
   PubMed Web of Science ®Google Scholar
• Yoon HY, Lee SH, et al. TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells. Neurochem Int 2002; 41(1)37–42
   PubMed Web of Science ®Google Scholar